Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH

Watchlist Manager
Fisher & Paykel Healthcare Corporation Ltd Logo
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Watchlist
Price: 38.34 NZD 1.51% Market Closed
Market Cap: 22.5B NZD
Have any thoughts about
Fisher & Paykel Healthcare Corporation Ltd?
Write Note

Fisher & Paykel Healthcare Corporation Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Fisher & Paykel Healthcare Corporation Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Fisher & Paykel Healthcare Corporation Ltd
NZX:FPH
Cash & Cash Equivalents
NZ$116.6m
CAGR 3-Years
4%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Truscreen Group Ltd
NZX:TRU
Cash & Cash Equivalents
NZ$2.7m
CAGR 3-Years
-20%
CAGR 5-Years
9%
CAGR 10-Years
N/A
No Stocks Found

Fisher & Paykel Healthcare Corporation Ltd
Glance View

Market Cap
22.5B NZD
Industry
Health Care

Nestled in the heart of New Zealand, Fisher & Paykel Healthcare Corporation Ltd. has emerged as a formidable player in the global healthcare market, largely due to its innovative spirit and relentless focus on respiratory care solutions. Originally part of Fisher & Paykel Industries, the healthcare division carved its own path in 2001, quickly becoming synonymous with high-quality medical devices. The company’s journey can be compared to a constant rhythm of innovation, particularly in areas that address obstructive sleep apnea, acute respiratory distress, and surgical humidification. Its revenue streams are primarily bolstered by a diverse array of products, including sleep apnea masks, humidifier systems for intensive care units, and related respiratory accessories. These offerings are not just technological marvels but are designed to improve patient outcomes and their quality of life, which resonates well with healthcare providers worldwide. Over the years, Fisher & Paykel Healthcare has strategically expanded its operations beyond its Kiwi roots, anchoring its presence in over 120 countries. This global footprint, coupled with a robust pipeline of patented products, enables sustained revenue growth and stability. The company’s financial health is driven by a business model that emphasizes research and development, ensuring that it remains at the forefront of medical innovation. By fostering close relationships with healthcare professionals and institutions, Fisher & Paykel not only gains invaluable insights to refine its products but also cultivates a loyal customer base. This enduring approach cements its position not only as a leader in the healthcare sector but also as a trusted partner in the critical mission to enhance patient care worldwide.

FPH Intrinsic Value
24.23 NZD
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Fisher & Paykel Healthcare Corporation Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
116.6m NZD

Based on the financial report for Sep 30, 2024, Fisher & Paykel Healthcare Corporation Ltd's Cash & Cash Equivalents amounts to 116.6m NZD.

What is Fisher & Paykel Healthcare Corporation Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
19%

Over the last year, the Cash & Cash Equivalents growth was 65%. The average annual Cash & Cash Equivalents growth rates for Fisher & Paykel Healthcare Corporation Ltd have been 4% over the past three years , 19% over the past five years .

Back to Top